Cannbiorx Life Sciences Stock Bond Positions Weight

ATNFW Stock

USD 0.01 0.0008 8.89%

CannBioRx Life Sciences fundamentals help investors to digest information that contributes to CannBioRx Life's financial success or failures. It also enables traders to predict the movement of CannBioRx Stock. The fundamental analysis module provides a way to measure CannBioRx Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CannBioRx Life stock.

Total Current Liabilities Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

CannBioRx Life Sciences Company Bond Positions Weight Analysis

CannBioRx Life's Percentage of fund asset invested in fixed income securities. About 30% of U.S. mutual funds invest in bonds.

Bond Percentage

% of Bonds

in the fund

More About Bond Positions Weight | All Equity Analysis

CannBioRx Bond Positions Weight Driver Correlations

Understanding the fundamental principles of building solid financial models for CannBioRx Life is extremely important. It helps to project a fair market value of CannBioRx Stock properly, considering its historical fundamentals such as Bond Positions Weight. Since CannBioRx Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CannBioRx Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CannBioRx Life's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Retained Earnings	Capital Surpluse	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Debt	Short Term Investments	Accounts Payable	Net Receivables	Good Will	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Intangible Assets	Long Term Debt	Current Deferred Revenue
Total Assets		0.45	0.14	0.64	0.4	0.11	0.87	0.85	0.02	-0.03	0.14	0.24	0.28	0.26	0.18	0.37	-0.28	0.28	0.19	0.27
Total Stockholder Equity	0.45		-0.17	0.48	0.85	0.52	0.63	-0.08	-0.05	-0.56	0.08	0.67	0.23	0.19	0.0	0.63	-0.31	0.27	0.0	0.21
Retained Earnings	0.14	-0.17		-0.65	-0.47	-0.72	-0.13	0.3	0.37	0.9	0.53	-0.28	0.9	0.92	0.94	0.47	-0.7	0.85	0.95	0.91
Capital Surpluse	0.64	0.48	-0.65		0.66	0.57	0.79	0.39	-0.14	-0.73	-0.24	0.35	-0.48	-0.51	-0.55	-0.11	0.3	-0.45	-0.55	-0.48
Total Liab	0.4	0.85	-0.47	0.66		0.7	0.65	-0.1	-0.16	-0.76	0.07	0.82	-0.09	-0.18	-0.26	0.46	-0.18	-0.09	-0.32	-0.09
Total Current Assets	0.11	0.52	-0.72	0.57	0.7		0.2	-0.23	-0.77	-0.76	-0.53	0.72	-0.48	-0.46	-0.72	0.15	0.42	-0.33	-0.72	-0.5
Short Term Debt	0.87	0.63	-0.13	0.79	0.65	0.2		0.59	0.22	-0.39	0.27	0.38	0.07	0.02	0.06	0.25	-0.24	0.07	0.03	0.07
Common Stock	0.85	-0.08	0.3	0.39	-0.1	-0.23	0.59		0.08	0.34	0.1	-0.17	0.22	0.23	0.24	0.05	-0.13	0.2	0.25	0.22
Net Debt	0.02	-0.05	0.37	-0.14	-0.16	-0.77	0.22	0.08		0.21	0.69	-0.42	0.32	0.23	0.56	-0.09	-0.51	0.12	0.53	0.34
Short Term Investments	-0.03	-0.56	0.9	-0.73	-0.76	-0.76	-0.39	0.34	0.21		0.31	-0.5	0.65	0.7	0.73	0.15	-0.4	0.61	0.76	0.66
Accounts Payable	0.14	0.08	0.53	-0.24	0.07	-0.53	0.27	0.1	0.69	0.31		0.17	0.55	0.46	0.75	0.34	-0.79	0.49	0.71	0.55
Net Receivables	0.24	0.67	-0.28	0.35	0.82	0.72	0.38	-0.17	-0.42	-0.5	0.17		0.01	-0.02	-0.13	0.55	-0.19	0.16	-0.17	-0.01
Good Will	0.28	0.23	0.9	-0.48	-0.09	-0.48	0.07	0.22	0.32	0.65	0.55	0.01		0.98	0.9	0.78	-0.87	0.92	0.92	1.0
Net Invested Capital	0.26	0.19	0.92	-0.51	-0.18	-0.46	0.02	0.23	0.23	0.7	0.46	-0.02	0.98		0.89	0.73	-0.76	0.96	0.91	0.97
Short Long Term Debt	0.18	0.0	0.94	-0.55	-0.26	-0.72	0.06	0.24	0.56	0.73	0.75	-0.13	0.9	0.89		0.5	-0.82	0.84	0.98	0.91
Capital Stock	0.37	0.63	0.47	-0.11	0.46	0.15	0.25	0.05	-0.09	0.15	0.34	0.55	0.78	0.73	0.5		-0.77	0.74	0.51	0.76
Net Working Capital	-0.28	-0.31	-0.7	0.3	-0.18	0.42	-0.24	-0.13	-0.51	-0.4	-0.79	-0.19	-0.87	-0.76	-0.82	-0.77		-0.71	-0.8	-0.87
Intangible Assets	0.28	0.27	0.85	-0.45	-0.09	-0.33	0.07	0.2	0.12	0.61	0.49	0.16	0.92	0.96	0.84	0.74	-0.71		0.88	0.9
Long Term Debt	0.19	0.0	0.95	-0.55	-0.32	-0.72	0.03	0.25	0.53	0.76	0.71	-0.17	0.92	0.91	0.98	0.51	-0.8	0.88		0.91
Current Deferred Revenue	0.27	0.21	0.91	-0.48	-0.09	-0.5	0.07	0.22	0.34	0.66	0.55	-0.01	1.0	0.97	0.91	0.76	-0.87	0.9	0.91

Click cells to compare fundamentals

Funds that have over 60% of asset value invested in bonds or or other fixed income securities would usually attract conservative investors.

Competition

Predict CannBioRx Life

In accordance with the recently published financial statements, CannBioRx Life Sciences has a Bond Positions Weight of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Correlation Analysis Now

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated

All Next

Launch Module

CannBioRx Fundamentals

	Return On Equity	-1.74
	Return On Asset	-0.52
	Number Of Shares Shorted	40.13 K
	EBITDA	(22.13 M)
	Net Income	(19.94 M)
	Total Debt	1.05 M
	Book Value Per Share	3.64 X
	Cash Flow From Operations	(10.92 M)
	Beta	0.22
	Market Capitalization	250.78 M
	Total Asset	5.26 M
	Retained Earnings	(127.34 M)
	Working Capital	(1.42 M)
	Net Asset	5.26 M

About CannBioRx Life Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CannBioRx Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CannBioRx Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CannBioRx Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for CannBioRx Stock Analysis

When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC